Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

HBIO Insider Trading

HARVARD BIOSCIENCE INC | Laboratory Analytical Instruments

Comprehensive Trading Performance Summary

The investment history of corporate insiders at HARVARD BIOSCIENCE INC provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Laboratory Analytical Instruments sector.

Last 7 Days
$0
Buys
$0
Sells
Last 30 Days Trend
$0
Buys
$0
Sells

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2017-02-08 00:11 2017-02-06 GREEN DAVID Director SELL $3.25 1,288 $4,186 928,810 -0.1%
2016-12-08 01:00 2016-12-06 LEWIS EARL R Director SELL $2.42 23,088 $55,873 392,012 -5.6%
2016-11-03 23:12 2016-11-03 Duchemin Jeffrey Director, Officer - Chief Executive Officer BUY $2.42 15,000 $36,300 462,623 +3.4%
2016-11-03 23:11 2016-11-02 Gagnon Robert E. Officer - Chief Financial Officer BUY $2.34 25,000 $58,450 267,549 +10.3%
2016-01-12 01:35 2015-12-02 LEWIS EARL R Director BUY $3.28 27,221 $89,285 389,800 +7.5%
2015-12-12 00:58 2015-12-10 Duchemin Jeffrey Director, Officer - Chief Executive Officer BUY $3.37 10,000 $33,700 160,210 +6.7%
2015-12-04 01:16 2015-12-03 UVEGES GEORGE Director BUY $3.32 3,000 $9,960 67,171 +4.7%
2015-11-17 00:15 2015-11-12 Gagnon Robert E. Officer - Chief Financial Officer BUY $2.93 1,500 $4,395 67,721 +2.3%
2015-11-10 04:20 2015-11-09 Gagnon Robert E. Officer - Chief Financial Officer BUY $3.08 3,000 $9,240 66,221 +4.7%
2015-09-02 23:22 2015-09-02 Duchemin Jeffrey Director, Officer - Chief Executive Officer BUY $4.41 2,000 $8,820 150,210 +1.3%
2015-09-01 23:25 2015-09-01 KENNEDY JOHN F Director BUY $4.33 2,000 $8,660 177,330 +1.1%
2015-07-18 04:10 2015-07-15 GREEN DAVID Director SELL $5.26 17,103 $89,958 474,953 -3.5%
2015-07-15 00:11 2015-07-10 GREEN DAVID Director SELL $5.28 51,597 $272,391 492,056 -9.5%
2015-04-28 03:52 2015-04-23 GREEN DAVID Director SELL $6.03 118,500 $714,555 529,253 -18.3%
2015-04-23 23:51 2015-04-20 GREEN DAVID Director SELL $6.23 123,997 $772,340 647,753 -16.1%
2015-04-18 00:33 2015-04-15 GREEN DAVID Director SELL $6.55 42,503 $278,603 771,750 -5.2%
2015-04-15 02:30 2015-04-10 GREEN DAVID Director SELL $6.61 80,168 $529,694 814,253 -9.0%
2015-02-11 01:26 2015-02-09 GREEN DAVID Director SELL $5.25 48,712 $255,738 894,421 -5.2%
2014-12-31 02:31 2014-12-30 GREEN DAVID Director SELL $5.25 16,173 $84,908 990,925 -1.6%
2014-12-30 02:54 2014-12-23 GREEN DAVID Director SELL $5.25 100,167 $525,877 1,007,098 -9.0%
2014-12-23 02:25 2014-12-18 GREEN DAVID Director SELL $5.02 80,202 $402,823 1,107,265 -6.8%
2014-11-22 00:44 2014-11-19 GREEN DAVID Director SELL $4.95 10,000 $49,500 1,187,467 -0.8%
2014-11-01 00:20 2014-10-29 GREEN DAVID Director SELL $4.97 117,654 $585,246 1,197,467 -8.9%
2013-08-29 17:12 2013-08-27 GRAZIANO CHANE 10% owner BUY $5.00 60,000 $300,000 3,105,150 +2.0%
2012-12-22 00:44 2012-12-19 GREEN DAVID Director, Officer - President OPT+S $4.05 136,146 $551,037 1,616,933 0.0%
2012-12-20 00:46 2012-12-17 GREEN DAVID Director, Officer - President OPT+S $4.09 32,208 $131,802 1,616,933 0.0%
2011-04-28 01:04 2011-04-25 GREEN DAVID Director, Officer - President SELL $5.96 14,500 $86,453 1,463,402 -1.0%
2011-04-07 02:05 2011-04-04 GREEN DAVID Director, Officer - President SELL $6.03 7,000 $42,177 1,477,902 -0.5%
2011-04-05 00:39 2011-03-31 GREEN DAVID Director, Officer - President SELL $5.96 400 $2,382 1,484,902 0.0%
2011-03-31 18:46 2011-03-29 GREEN DAVID Director, Officer - President SELL $6.05 78,100 $472,161 1,485,302 -5.0%
2010-09-16 23:10 2010-09-13 GRAZIANO CHANE Director, Officer, 10% owner - Chief Executive Officer BUY $3.58 100,000 $358,070 3,798,481 +2.7%
2009-09-16 23:15 2009-09-15 LEWIS EARL R Director BUY $3.73 20,000 $74,516 70,000 +40.0%
2009-09-16 23:15 2009-09-15 UVEGES GEORGE Director BUY $3.70 2,500 $9,250 10,000 +33.3%
2009-03-26 22:24 2009-03-24 Skystone Advisors LLC 10% owner SELL $3.02 7,160 $21,610 3,744,819 -0.2%
2009-03-17 01:12 2009-03-12 Skystone Advisors LLC 10% owner SELL $2.75 7,958 $21,885 3,751,979 -0.2%
2009-03-10 00:54 2009-03-05 GREEN DAVID Director, Officer - President BUY $2.49 453 $1,128 1,441,011 +0.0%
2009-03-05 00:11 2009-03-02 GREEN DAVID Director, Officer - President BUY $2.49 3,274 $8,149 1,440,558 +0.2%
2009-03-02 20:12 2009-02-26 GREEN DAVID Director, Officer - President BUY $2.45 14,589 $35,691 1,437,284 +1.0%
2009-02-05 01:12 2009-02-02 GREEN DAVID Director, Officer - President BUY $2.48 822 $2,041 1,422,695 +0.1%
2009-01-30 00:04 2009-01-27 GREEN DAVID Director, Officer - President BUY $2.47 2,100 $5,177 1,421,873 +0.1%
2008-12-24 01:54 2008-12-19 GREEN DAVID Director, Officer - President BUY $2.43 20,000 $48,644 1,419,773 +1.4%
2008-12-09 20:39 2008-12-05 GREEN DAVID Director, Officer - President BUY $2.00 100 $200 1,399,773 +0.0%
2008-12-06 01:32 2008-12-03 GREEN DAVID Director, Officer - President BUY $1.97 11,400 $22,502 1,399,673 +0.8%
2008-12-04 02:31 2008-12-01 LEWIS EARL R Director BUY $2.05 25,000 $51,148 50,000 +100.0%
2008-12-04 02:30 2008-12-01 GREEN DAVID Director, Officer - President BUY $1.99 13,200 $26,286 1,388,273 +1.0%
2008-11-26 22:54 2008-11-26 UVEGES GEORGE Director BUY $1.96 2,500 $4,898 7,500 +50.0%
2008-05-21 00:26 2008-05-16 HSO LIMITED PARTNERSHIP 10% owner SELL $5.00 733,300 $3,666,500 2,757,257 -21.0%
2008-05-21 00:25 2008-05-16 Skystone Advisors LLC 10% owner SELL $5.00 1,000,000 $5,000,000 3,759,937 -21.0%
2008-01-04 01:33 2007-12-31 Skystone Advisors LLC 10% owner BUY $4.51 4,362 $19,663 4,759,937 +0.1%
2007-12-12 22:52 2007-12-11 UVEGES GEORGE Director BUY $4.15 5,000 $20,742 5,000 +100.0%
SHOW ENTRIES
51-100 OF 175

How to Interpret $HBIO Trades

Not every insider transaction in HARVARD BIOSCIENCE INC is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $HBIO shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for HBIO

Insider activity data for HARVARD BIOSCIENCE INC is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $HBIO, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.